MEA Cardiovascular Monitoring & Diagnostic Devices Market

MEA Cardiovascular Monitoring & Diagnostic Devices Market Size (2023 to 2028)

The Cardiovascular Diagnostic and Monitoring Devices Market in the Middle East & Africa was worth 214.00 million in 2023 and estimated to be growing at a CAGR of 8.76%, to reach 325.65 million by 2028.

Cardiovascular disease is a medical condition that affects the structure and function of organs associated with the heart's function and its circulation. Cardio Vascular diseases are the primary cause of death and witnessing a high rise in prevalence. A large number of people are being diagnosed with cardiovascular diseases such as periphery artery diseases, coronary artery diseases, congenital heart diseases, and pulmonary conditions, shifting focus towards preventative healthcare.

The Middle East & Africa market for cardiovascular devices is majorly driven by factors such as an increasing number of people suffering from diabetes and obesity and growing risks related to hypertension and heart muscle weakening. Advancements in Technology have enabled portability features such as portability in performing various tests and adding to the growth of the Cardiovascular Monitoring market.

However, unclear reimbursement policies, stringent government regulations for product approvals, and the high cost of devices are major factors restraining market growth.

This research report on the MEA Cardiovascular Monitoring & Diagnostic Devices Market has been segmented and sub-segmented into the following categories:

By Product:

• ECG Systems
  • Resting ECG Systems
  • Stress ECG Systems
• Event Monitors
• Holter Monitors
• Implantable Loop Recorders
• ECG Management Systems

By Country: 

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Regionally, Middle-East is the largest market within this region due to high disposable income and increasing awareness about diagnostic procedures. At the same time, Africa is estimated to be the fastest-growing due to its high population base and many untapped markets providing a greater opportunity for growth.

Noteworthy companies operating in the MEA Cardiovascular Monitoring & Diagnostic Devices Market GE Healthcare and Phillips Healthcare, Siemens Healthcare, Boston Scientific Corporation, St. Jude Medical, Inc., Nihon Kohden Corporation, and Welch Allyn, Inc.